Disease related mutations in PI3Kγ disrupt regulatory C-terminal dynamics and reveal a path to selective inhibitors

  1. Manoj K Rathinaswamy
  2. Zied Gaieb
  3. Kaelin D Fleming
  4. Chiara Borsari
  5. Noah J Harris
  6. Brandon J Moeller
  7. Matthias P Wymann
  8. Rommie E Amaro
  9. John E Burke  Is a corresponding author
  1. University of Victoria, Canada
  2. University of California, San Diego, United States
  3. University of Basel, Switzerland

Abstract

Class I Phosphoinositide 3-kinases (PI3Ks) are master regulators of cellular functions, with the class IB PI3K catalytic subunit (p110g) playing key roles in immune signalling. p110g is a key factor in inflammatory diseases, and has been identified as a therapeutic target for cancers due to its immunomodulatory role. Using a combined biochemical/biophysical approach, we have revealed insight into regulation of kinase activity, specifically defining how immunodeficiency and oncogenic mutations of R1021 in the C-terminus can inactivate or activate enzyme activity. Screening of inhibitors using HDX-MS revealed that activation loop-binding inhibitors induce allosteric conformational changes that mimic those in the R1021C mutant. Structural analysis of advanced PI3K inhibitors in clinical development revealed novel binding pockets that can be exploited for further therapeutic development. Overall this work provides unique insights into regulatory mechanisms that control PI3Kg kinase activity, and shows a framework for the design of PI3K isoform and mutant selective inhibitors.

Data availability

The crystallography data has been deposited in the protein data bank with accession numbers (PDB: 7JWE, 7JX0, 7JWZ). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository[83] with the dataset identifier PXD021132. All data generated or analyzed during this study are included in the manuscript and supporting files. Specifically biochemical kinase assay data are included in the source data files.

The following previously published data sets were used

Article and author information

Author details

  1. Manoj K Rathinaswamy

    Biochemistry and Microbiology, University of Victoria, Victoria, Canada
    Competing interests
    The authors declare that no competing interests exist.
  2. Zied Gaieb

    Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Kaelin D Fleming

    Biochemistry and Microbiology, University of Victoria, Victoria, Canada
    Competing interests
    The authors declare that no competing interests exist.
  4. Chiara Borsari

    Department of Biomedicine, University of Basel, Basel, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4688-8362
  5. Noah J Harris

    Biochemistry and Microbiology, University of Victoria, Victoria, Canada
    Competing interests
    The authors declare that no competing interests exist.
  6. Brandon J Moeller

    Biochemistry and Microbiology, University of Victoria, Victoria, Canada
    Competing interests
    The authors declare that no competing interests exist.
  7. Matthias P Wymann

    Department of Biomedicine, University of Basel, Basel, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3349-4281
  8. Rommie E Amaro

    Chemistry and Biochemistry, National Biomedical Computation Resource, University of California, San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. John E Burke

    Biochemistry and Microbiology, University of Victoria, Victoria, Canada
    For correspondence
    jeburke@uvic.ca
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7904-9859

Funding

Cancer Research Society (CRS-24368)

  • John E Burke

Michael Smith Foundation for Health Research (17686)

  • John E Burke

Canadian Institutes of Health Research (New Investigator)

  • John E Burke

National Institutes of Health (GM132826)

  • Zied Gaieb
  • Rommie E Amaro

Stiftung FHNW (341)

  • Matthias P Wymann

Swiss National Science (310030_189065)

  • Matthias P Wymann

Novartis Foundation (14B095)

  • Matthias P Wymann

Innosuisse - Schweizerische Agentur für Innovationsförderung (37213.1 IP-LS)

  • Matthias P Wymann

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Rathinaswamy et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,397
    views
  • 366
    downloads
  • 34
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Manoj K Rathinaswamy
  2. Zied Gaieb
  3. Kaelin D Fleming
  4. Chiara Borsari
  5. Noah J Harris
  6. Brandon J Moeller
  7. Matthias P Wymann
  8. Rommie E Amaro
  9. John E Burke
(2021)
Disease related mutations in PI3Kγ disrupt regulatory C-terminal dynamics and reveal a path to selective inhibitors
eLife 10:e64691.
https://doi.org/10.7554/eLife.64691

Share this article

https://doi.org/10.7554/eLife.64691

Further reading

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Stephanie M Stuteley, Ghader Bashiri
    Insight

    In the bacterium M. smegmatis, an enzyme called MftG allows the cofactor mycofactocin to transfer electrons released during ethanol metabolism to the electron transport chain.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Yi-Hsuan Lin, Tae Hun Kim ... Hue Sun Chan
    Research Article

    Liquid-liquid phase separation (LLPS) involving intrinsically disordered protein regions (IDRs) is a major physical mechanism for biological membraneless compartmentalization. The multifaceted electrostatic effects in these biomolecular condensates are exemplified here by experimental and theoretical investigations of the different salt- and ATP-dependent LLPSs of an IDR of messenger RNA-regulating protein Caprin1 and its phosphorylated variant pY-Caprin1, exhibiting, for example, reentrant behaviors in some instances but not others. Experimental data are rationalized by physical modeling using analytical theory, molecular dynamics, and polymer field-theoretic simulations, indicating that interchain ion bridges enhance LLPS of polyelectrolytes such as Caprin1 and the high valency of ATP-magnesium is a significant factor for its colocalization with the condensed phases, as similar trends are observed for other IDRs. The electrostatic nature of these features complements ATP’s involvement in π-related interactions and as an amphiphilic hydrotrope, underscoring a general role of biomolecular condensates in modulating ion concentrations and its functional ramifications.